CNB Bank’s Helus Pharma HELP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$49 Hold
4
– – ﹤0.01% 510
2026
Q2
$26 Hold
4
– – ﹤0.01% 518
2026
Q1
$19 Hold
4
– – ﹤0.01% 522
2025
Q4
$33 Hold
4
– – ﹤0.01% 507
2025
Q3
$24 Hold
4
– – ﹤0.01% 504
2025
Q2
$34 Hold
4
– – ﹤0.01% 501
2025
Q1
$25 Hold
4
– – ﹤0.01% 491
2024
Q4
$35 Buy
+4
New +$41 ﹤0.01% 499
2024
Q3
– Sell
-5
Closed -$50 – 529
2024
Q2
$50 Hold
5
– – ﹤0.01% 508
2024
Q1
$77 Hold
5
– – ﹤0.01% 493
2023
Q4
$76 Hold
5
– – ﹤0.01% 480
2023
Q3
$98 Hold
5
– – ﹤0.01% 490
2023
Q2
$70 Hold
5
– – ﹤0.01% 440
2023
Q1
$71 Hold
5
– – ﹤0.01% 478
2022
Q4
$55 Hold
5
– – ﹤0.01% 456
2022
Q3
$0 Hold
5
– – ﹤0.01% 462
2022
Q2
$0 Buy
+5
New – ﹤0.01% 481
2022
Q1
– Sell
-5
Closed – – 501
2021
Q4
$0 Hold
5
– – ﹤0.01% 468
2021
Q3
$1K Buy
+5
New +$438 ﹤0.01% 397

Other funds holding HELP

CNB Bank's HELP Position: Q3 2026 in Review

CNB Bank held its Helus Pharma (HELP) position steady in Q3 2026 at 4 shares worth $49. The position accounts for ﹤0.01% of the portfolio, ranked #510.

CNB Bank first reported a position in HELP in Q3 2021 and has held it in 19 quarters since. The position peaked at $1K in Q3 2021. 110 funds tracked by Wall St. Rank hold HELP as of Q3 2026.

  • CNB Bank held 4 shares of Helus Pharma worth $49 as of Q3 2026.
  • CNB Bank left its Helus Pharma share count unchanged in Q3 2026.
  • Helus Pharma made up ﹤0.01% of CNB Bank's portfolio in Q3 2026, its #510 holding.
  • CNB Bank first reported a position in Helus Pharma in Q3 2021 and has held it in 19 quarters since.
  • CNB Bank's Helus Pharma position peaked at $1K in Q3 2021.
  • 110 funds tracked by Wall St. Rank held Helus Pharma as of Q3 2026.

Based on CNB Bank's 13F filing for Q3 2026, filed 9 Nov 2026.